SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-24-021409
Filing Date
2024-02-01
Accepted
2024-02-01 07:38:58
Documents
5
Group Members
LANTHEUS ALPHA THERAPY, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d785059dsc13d.htm SC 13D 97935
2 EX-99.4 d785059dex994.htm EX-99.4 119696
3 EX-99.5 d785059dex995.htm EX-99.5 8111
4 EX-99.6 d785059dex996.htm EX-99.6 8104
5 EX-99.7 d785059dex997.htm EX-99.7 4167
  Complete submission text file 0001193125-24-021409.txt   240152
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 (509) 375-1202
Perspective Therapeutics, Inc. (Subject) CIK: 0000728387 (see all company filings)

IRS No.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-80930 | Film No.: 24585057
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filed by) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)